183 related articles for article (PubMed ID: 15743503)
21. [The association of sulfotransferase1A1 His allele and breast cancer in Han ethnic Chinese women].
Han DF; Zhou X; Hu MB; Wang CH; Xie W; Zheng F; Liu F
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1759-63. PubMed ID: 14642079
[TBL] [Abstract][Full Text] [Related]
22. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.
Ishibe N; Hankinson SE; Colditz GA; Spiegelman D; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
Cancer Res; 1998 Feb; 58(4):667-71. PubMed ID: 9485019
[TBL] [Abstract][Full Text] [Related]
23. Sulfotransferase1A1 and risk of postmenopausal breast cancer.
Jerevall PL; Ahmadi A; Bergman M; Stål O; Wingren S
Anticancer Res; 2005; 25(3c):2515-7. PubMed ID: 16080486
[TBL] [Abstract][Full Text] [Related]
24. Effect of SULT1A1 and NAT2 genetic polymorphism on the association between cigarette smoking and colorectal adenomas.
Tiemersma EW; Bunschoten A; Kok FJ; Glatt H; de Boer SY; Kampman E
Int J Cancer; 2004 Jan; 108(1):97-103. PubMed ID: 14618622
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype.
Delfino RJ; Smith C; West JG; Lin HJ; White E; Liao SY; Gim JS; Ma HL; Butler J; Anton-Culver H
Pharmacogenetics; 2000 Jul; 10(5):461-9. PubMed ID: 10898115
[TBL] [Abstract][Full Text] [Related]
26. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
Int J Cancer; 2005 Apr; 114(4):579-84. PubMed ID: 15609332
[TBL] [Abstract][Full Text] [Related]
27. Modifying effects of sulfotransferase 1A1 gene polymorphism on the association of breast cancer risk with body mass index or endogenous steroid hormones.
Yang G; Gao YT; Cai QY; Shu XO; Cheng JR; Zheng W
Breast Cancer Res Treat; 2005 Nov; 94(1):63-70. PubMed ID: 16175316
[TBL] [Abstract][Full Text] [Related]
28. Association of genotypes of carcinogen-activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N-acetyltransferase NAT2, with urothelial cancer in a Japanese population.
Ozawa S; Katoh T; Inatomi H; Imai H; Kuroda Y; Ichiba M; Ohno Y
Int J Cancer; 2002 Dec; 102(4):418-21. PubMed ID: 12402313
[TBL] [Abstract][Full Text] [Related]
29. Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study.
Zheng L; Wang Y; Schabath MB; Grossman HB; Wu X
Cancer Lett; 2003 Dec; 202(1):61-9. PubMed ID: 14643027
[TBL] [Abstract][Full Text] [Related]
30. NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women.
van der Hel OL; Peeters PH; Hein DW; Doll MA; Grobbee DE; Kromhout D; Bueno de Mesquita HB
Pharmacogenetics; 2003 Jul; 13(7):399-407. PubMed ID: 12835615
[TBL] [Abstract][Full Text] [Related]
31. Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer.
Slattery ML; Edwards S; Curtin K; Schaffer D; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):882-9. PubMed ID: 14504199
[TBL] [Abstract][Full Text] [Related]
32. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence.
Huang CS; Chern HD; Shen CY; Hsu SM; Chang KJ
Int J Cancer; 1999 Jul; 82(2):175-9. PubMed ID: 10389748
[TBL] [Abstract][Full Text] [Related]
33. Sulfotransferase 1A1 (SULT1A1) polymorphism and breast cancer risk in Chinese women.
Han DF; Zhou X; Hu MB; Wang CH; Xie W; Tan XD; Zheng F; Liu F
Toxicol Lett; 2004 Apr; 150(2):167-77. PubMed ID: 15093672
[TBL] [Abstract][Full Text] [Related]
34. Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy.
Nowell S; Sweeney C; Winters M; Stone A; Lang NP; Hutchins LF; Kadlubar FF; Ambrosone CB
J Natl Cancer Inst; 2002 Nov; 94(21):1635-40. PubMed ID: 12419790
[TBL] [Abstract][Full Text] [Related]
35. Active and passive smoking and risk of breast cancer by age 50 years among German women.
Kropp S; Chang-Claude J
Am J Epidemiol; 2002 Oct; 156(7):616-26. PubMed ID: 12244030
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.
Cheng TC; Chen ST; Huang CS; Fu YP; Yu JC; Cheng CW; Wu PE; Shen CY
Int J Cancer; 2005 Jan; 113(3):345-53. PubMed ID: 15455371
[TBL] [Abstract][Full Text] [Related]
37. Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study.
Tang D; Rundle A; Mooney L; Cho S; Schnabel F; Estabrook A; Kelly A; Levine R; Hibshoosh H; Perera F
Breast Cancer Res Treat; 2003 Mar; 78(2):217-22. PubMed ID: 12725421
[TBL] [Abstract][Full Text] [Related]
38. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
Verla-Tebit E; Wang-Gohrke S; Chang-Claude J
Breast Cancer Res; 2005; 7(4):R455-64. PubMed ID: 15987450
[TBL] [Abstract][Full Text] [Related]
39. Relation of breast cancer with passive and active exposure to tobacco smoke.
Morabia A; Bernstein M; Héritier S; Khatchatrian N
Am J Epidemiol; 1996 May; 143(9):918-28. PubMed ID: 8610705
[TBL] [Abstract][Full Text] [Related]
40. Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis.
Wang Y; Spitz MR; Tsou AM; Zhang K; Makan N; Wu X
Lung Cancer; 2002 Feb; 35(2):137-42. PubMed ID: 11804685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
